Proteasome inhibition: a new anti-inflammatory strategy. - Wikidata - wikimedia - TriplyDB

Proteasome inhibition: a new anti-inflammatory strategy.

Proteasome inhibition: a new anti-inflammatory strategy.

http://www.wikidata.org/entity/Q35109750

about

Charting the NF-κB pathway interactome map A functional SNP in PSMA6 confers risk of myocardial infarction in the Japanese population The ubiquitin proteasome system and myocardial ischemia Systemic proteasome inhibition triggers neurodegeneration in a transgenic mouse model expressing human α-synuclein under oligodendrocyte promoter: implications for multiple system atrophy.Ubiquitin-regulated nuclear-cytoplasmic trafficking of the Nipah virus matrix protein is important for viral budding.Comparative genomics RNAi screen identifies Eftud2 as a novel regulator of innate immunity.The ubiquitin-proteasome system as a drug target in cerebrovascular disease: therapeutic potential of proteasome inhibitors.Salinosporamide natural products: Potent 20 S proteasome inhibitors as promising cancer chemotherapeutics.The treatment of traumatic brain injury with velcade.Effects of interventions on oxidative stress and inflammation of cardiovascular diseases Advances in and applications of proteasome inhibitors The protective effects of the proteasome inhibitor bortezomib (velcade) on ischemia-reperfusion injury in the rat retina.The effect of bortezomib on expression of inflammatory cytokines and survival in a murine sepsis model induced by cecal ligation and puncture.The interplay between autophagy and the ubiquitin-proteasome system in cardiac proteotoxicity Evidence that proteosome inhibitors and chemical chaperones can rescue the activity of retinol dehydrogenase 12 mutant T49M.Transgenic inhibition of astroglial NF-kappa B improves functional outcome in experimental autoimmune encephalomyelitis by suppressing chronic central nervous system inflammation Cyclin-dependent kinase 5 regulates PSD-95 ubiquitination in neurons.Comparison of the effects of hexavalent chromium in the alimentary canal of F344 rats and B6C3F1 mice following exposure in drinking water: implications for carcinogenic modes of action.Non-viral delivery of nuclear factor-kappaB decoy ameliorates murine inflammatory bowel disease and restores tissue homeostasis.Cell therapy for autoimmune diseases: does it have a future?Seven-transmembrane receptors and ubiquitination Therapeutic proteasome inhibition in experimental acute pancreatitis Identification of key genes and pathways for peri-implantitis through the analysis of gene expression data.Inhibition of astroglial nuclear factor kappaB reduces inflammation and improves functional recovery after spinal cord injury.The ubiquitin-proteasome pathway in viral infections.Therapeutic potential of selectin antagonists in psoriasis.Identification of innate immunity genes and pathways using a comparative genomics approach.Proteasomal inhibition after injury prevents fibrosis by modulating TGF-β(1) signalling.Minireview: ubiquitination-regulated G protein-coupled receptor signaling and trafficking From bortezomib to other inhibitors of the proteasome and beyond.Posttranscriptional control of NLRP3 inflammasome activation in colonic macrophages.The Nuclear Zinc Finger Protein Zfat Maintains FoxO1 Protein Levels in Peripheral T Cells by Regulating the Activities of Autophagy and the Akt Signaling Pathway.Caffeic Acid Phenylethyl Ester and MG-132 Have Apoptotic and Antiproliferative Effects on Leukemic Cells But Not on Normal Mononuclear Cells.Bortezomib reduces neointimal hyperplasia in a rat carotid artery injury model.Feed-forward signaling of TNF-alpha and NF-kappaB via IKK-beta pathway contributes to insulin resistance and coronary arteriolar dysfunction in type 2 diabetic mice NF-kappaB signaling pathway and its therapeutic implications in human diseases.Targeting NF-kappaB: a promising molecular therapy in inflammatory arthritis.Effect of a low dose of proteasome inhibitor on cell death and gene expression in neonatal rat cardiomyocyte cultures exposed to anoxia-reoxygenation Bortezomib followed by autologous stem cell transplantation in a patient with rheumatoid arthritis: A case report and review of the literature.Proteasomal regulation of pulmonary fibrosis.

P2860

Q21134745-DAFAF566-E871-459D-AE51-93A3BB091059 Q24297364-3342E465-53D8-464A-9EFD-722A9E8336C8 Q28280898-67385D93-3F36-48DB-80C6-DFA0DAEE9E80 Q30516504-57411DDD-65DD-438C-9035-5CA744CF8BD3 Q33750025-2007E91A-68D0-4E29-AC6E-575CEAFEDCA1 Q33779529-AED63C8B-C775-4035-9040-7C6171744B4A Q33892755-AAADACBD-9F67-436C-8EFF-E2493CF445E7 Q34142223-4704C1E2-4FEF-42C2-BFD1-C8AB1AE081B1 Q34254813-9AEA595E-257A-427A-955B-B6A479954226 Q34538729-534B2604-6E5F-4669-B16B-45BDA23AA7FB Q34594744-15772DA7-FF57-4169-A146-C4A64BB5323A Q34731408-EF6445BF-97D4-4A85-9E69-0AA4188DA2EB Q34774088-D6222647-6DDF-474F-A767-25ABBB55A031 Q34778984-4EB3CB98-A950-460A-9150-0874C64BF81D Q34917584-FC1B3C2B-F356-43B2-A209-8603932BF656 Q34919012-5F893432-71FD-4287-B860-0CF1CCE56164 Q35306317-BDA4D4FD-6E37-4989-B950-F34399149A50 Q35626804-6A3C33BD-0EE9-45A9-B42B-1E9E4C060192 Q35761406-424D336B-65A3-4197-9F20-7771DCEEA18E Q35916008-6748741B-AC8B-460B-993E-3B2A8B838617 Q35951259-9D04A784-F39E-4C55-AC21-8DE547AB36A9 Q36179048-D5B0D450-670D-4B4E-A929-D88273474BC9 Q36387944-D082ABEE-C5FA-4FF6-B33D-91C811670D47 Q36402894-F3B38B7E-29E6-43D9-A1FF-11A7C568D861 Q36538328-B547811A-FDB1-4127-A766-9AE3D5401CE3 Q36543080-B71F42B7-600B-45CF-80E6-25319B045BF8 Q36657572-C875B42D-45DD-4426-8704-C7F5E8892536 Q36678523-97B305B4-3126-4FE7-A121-FD14AB5FA78B Q36714881-06BED812-4AFB-45E8-9F42-D2995A2F0981 Q36852277-8FCD3011-477E-4FAA-9913-4514BD07A0DD Q36957892-3C78F43E-FD14-47F2-BEDA-531C8150AB91 Q37098954-F863E7E6-B7A6-4E37-994F-DDF35148604F Q37109468-DBD804E4-A9A7-4E8C-B1DE-823A8D37BB12 Q37256678-2AAACE53-C2E2-4334-BF1A-ABE2BD675FAE Q37276227-96A1D7B3-EE6A-4B67-B954-EC9D3E8DDEFA Q37293337-8EA23175-60A9-4B45-9A0C-1FBEE3F748DB Q37293344-6F1987B9-F624-45E1-B708-C07BC130DC41 Q37293706-C553C371-C661-4E77-A05A-FE8AC63B0A3D Q37552226-4C0C67E4-01DD-4B2F-8B3B-2B1D823F17F6 Q37693531-B553B381-DB49-4CB0-BA41-A86DEA3317B5

P2860

Proteasome inhibition: a new anti-inflammatory strategy.

http://www.wikidata.org/entity/Q35109750

description

2003 nî lūn-bûn

@nan

2003 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի մարտին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Proteasome inhibition: a new anti-inflammatory strategy.

@ast

Proteasome inhibition: a new anti-inflammatory strategy.

@en

type

label

Proteasome inhibition: a new anti-inflammatory strategy.

@ast

Proteasome inhibition: a new anti-inflammatory strategy.

@en

prefLabel

Proteasome inhibition: a new anti-inflammatory strategy.

@ast

Proteasome inhibition: a new anti-inflammatory strategy.

@en

P1433

Q35109750-9FDF6FA0-DB55-476E-87BE-AE6461493FF7

P1476

Q35109750-EBEFEE3B-D0EC-49DE-A8C5-17C9BC1451B5

P2093

Q35109750-67FF67DA-39BA-4A37-A7EE-9A831BA466EB

Q35109750-8DD24B72-C6CF-443C-942A-39239E38030B

Q35109750-BC4B4991-7ADB-44E9-A874-E1B64D363E7A

P2860

Q35109750-00240084-6874-40BE-A8AA-33D7F8BFAD86

Q35109750-016ACA0D-37B8-4CC0-9823-75D2972426FF

Q35109750-06941E33-27C2-4C94-9768-C94CBB74337F

Q35109750-13C411A5-CB41-4303-8B8F-9E0A0AE65278

Q35109750-173DF1F0-337F-4FE0-8F0E-58B157062F90

Q35109750-19C1E24F-E92C-4D23-A414-D0B6C786CD71

Q35109750-2354ADE3-ECF9-4BCC-962A-F865B36DF03B

Q35109750-26F10DCA-CCEB-46A5-B048-C89D1D1B9B81

Q35109750-2A0BEFF3-C63D-470A-ACDE-6EA4A498098F

Q35109750-2A94CAB2-CB31-48D8-BD86-A0E64FBBABD2

P2888

Q35109750-260394D3-2E82-4C19-A7A5-8FD0556828DA

P304

Q35109750-53DC30C5-53BD-4A57-A738-95DFF26FEAB1

P31

Q35109750-B88B07C0-6281-458C-9454-6602152DAE63

P356

Q35109750-2EACCA0D-F374-458B-997A-83F68927523B

P433

Q35109750-A647E1FF-17C2-4663-8E70-6401522E1B25

P478

Q35109750-F955AFC3-330D-46F3-9E63-922F8C3CB826

P577

Q35109750-AD6214BE-7F65-4301-AE6B-82DFACFD0981

P698

Q35109750-B4D68368-CA7E-4D15-91AC-D4815388D61C

P921

Q35109750-8B8DC7AE-8238-40C3-BE9B-68D70AEC2158

P356

S00109-003-0422-2

P1433

Journal of Molecular Medicine

P1476

Proteasome inhibition: a new anti-inflammatory strategy.

@en

P2093

Peter J Elliott

http://www.w3.org/2001/XMLSchema#string

Thomas Matthias Zollner

http://www.w3.org/2001/XMLSchema#string

Wolf-Henning Boehncke

http://www.w3.org/2001/XMLSchema#string

P2860

A giant protease with potential to substitute for some functions of the proteasome

The NF-kappa B and I kappa B proteins: new discoveries and insights

Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity

The proteasome: a novel target for cancer chemotherapy

Proteasome subunits, low-molecular-mass polypeptides 2 and 7 are hyperexpressed by target cells in autoimmune thyroid disease but not in insulin-dependent diabetes mellitus: implications for autoimmunity

Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules

New insights into proteasome function: from archaebacteria to drug development

Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin

Regulation of rheumatoid synoviocyte proliferation by endogenous p53 induction

The ubiquitin-proteasome pathway and proteasome inhibitors

P2888

s00109-003-0422-2

P304

235-245

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00109-003-0422-2

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

81

http://www.w3.org/2001/XMLSchema#string

P577

2003-03-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12700891

http://www.w3.org/2001/XMLSchema#string

P921